Benitec Biopharma Inc. (BNTC)
NASDAQ · Healthcare
Benitec Biopharma Inc. Operating Income 2019–2024
Benitec Biopharma Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Benitec Biopharma Inc. operating income for the quarter ending March 31, 2026 was -13.6 M, a 11.43% decrease year-over-year.
- Benitec Biopharma Inc. operating income for the twelve months ending March 31, 2026 was -52.1 M, a 88.32% increase year-over-year.
- Benitec Biopharma Inc. annual operating income for 2024 was -22.5 M, a 17.87% increase from 2023.
- Benitec Biopharma Inc. annual operating income for 2023 was -19.1 M, a 6.87% increase from 2022.
- Benitec Biopharma Inc. annual operating income for 2022 was -17.9 M, a 31.32% increase from 2021.
- Benitec Biopharma Inc. annual operating income for 2021 was -13.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Benitec Biopharma Inc. Operating Income — FAQ
Benitec Biopharma Inc. (BNTC) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Benitec Biopharma Inc.'s operating income?
Benitec Biopharma Inc. (BNTC) reported operating income of -$22M for fiscal 2024.
Where can I see BNTC's operating income history?
The chart and table above show Benitec Biopharma Inc.'s operating income by year and by quarter, including the growth rate.